Greatest effect of HPV vaccination from school-based programmes (Q41447000)

30 September 2017

title

Greatest effect of HPV vaccination from school-based programmes (English)

1 reference

30 September 2017

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25744473%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

D Regan

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25744473%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

David G Regan

series ordinal

1

1 reference

30 September 2017

language of work or name

1 reference

3 March 2015

1 reference

Lancet Infectious Diseases

30 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25744473%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25744473%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25744473%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

497-498

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25744473%20AND%20SRC:MED&resulttype=core&format=json

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

5 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970078-2

7 January 2021

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970078-2

7 January 2021

Efficacy, duration of immunity and cross protection after HPV vaccination: a review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970078-2

7 January 2021

Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970078-2

7 January 2021

Prophylactic human papillomavirus vaccines: will they do their job?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970078-2

7 January 2021

Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970078-2

7 January 2021

Reduction of HPV infections through vaccination among at-risk urban adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970078-2

7 January 2021

Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970078-2

7 January 2021

Examining inequalities in the uptake of the school-based HPV vaccination programme in England: a retrospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970078-2

7 January 2021

Using a school-based approach to deliver immunization—global update

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970078-2

7 January 2021

Barriers to better three-dose coverage with HPV vaccination in school-based programs.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970078-2

7 January 2021

Near elimination of genital warts in Australia predicted with extension of human papillomavirus vaccination to males.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970078-2

7 January 2021

10.1016/S1473-3099(15)70078-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25744473%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference